Literature DB >> 25721582

Phosphaturic mesenchymal tumor of the tibia with oncogenic osteomalacia in a teenager.

Shannon G Farmakis1, Marilyn J Siegel.   

Abstract

Phosphaturic mesenchymal tumor is an uncommon cause of a paraneoplastic syndrome that can be associated with osteogenic osteomalacia. This tumor most commonly occurs in middle-aged men and women. We report a rare case of a phosphaturic mesenchymal tumor in a 16-year-old girl with multiple fractures as a result of severe osteoporosis. CT and MRI showed a mass arising from the tibia.

Entities:  

Mesh：

Year:  2015        PMID： 25721582     DOI： 10.1007/s00247-015-3301-4

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  8 in total

Review 1.  Oncogenic osteomalacia.

Authors:  M Sundaram; E F McCarthy
Journal:  Skeletal Radiol       Date:  2000-03       Impact factor: 2.199

2.  68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.

Authors:  Stefan Breer; Thomas Brunkhorst; F Timo Beil; Kersten Peldschus; Max Heiland; Susanne Klutmann; Florian Barvencik; Jozef Zustin; Klaus-Friedrich Gratz; Michael Amling
Journal:  Bone       Date:  2014-04-24       Impact factor: 4.398

3.  Diagnosis of phosphaturic mesenchymal tumor (mixed connective tissue type) by cytopathology.

Authors:  Josette William; William Laskin; Ritu Nayar; Denise De Frias
Journal:  Diagn Cytopathol       Date:  2011-02-14       Impact factor: 1.582

4.  Concordance between whole-body scintigraphy 111In-octreotide and 99mTc-sestamibi uptake in the detection of four tumor-induced osteomalacia cases.

Authors:  Marcela Paula Ferraz; Tomoco Watanabe; Heitor Naoki Sado; Carla Rachel Ono; Carlos Alberto Buchpiguel; Pedro Henrique Silveira Correa; Regina Matsunaga Martin
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

5.  Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.

Authors:  Kanhaiyalal Agrawal; Sanjay Bhadada; Bhagwant Rai Mittal; Jaya Shukla; Ashwani Sood; Anish Bhattacharya; Anil Bhansali
Journal:  Clin Nucl Med       Date:  2015-01       Impact factor: 7.794

6.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

Authors:  N Weidner; D Santa Cruz
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

Review 7.  Oncogenic osteomalacia.

Authors:  Kelli Andresen Edmister; Murali Sundaram
Journal:  Semin Musculoskelet Radiol       Date:  2002-09       Impact factor: 1.777

8.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394
  8 in total
  1 in total

1.  CT and MR imaging features in phosphaturic mesenchymal tumor-mixed connective tissue: A case report.

Authors:  Zhenshan Shi; Yiqiong Deng; Xiumei Li; Yueming Li; Dairong Cao; Vikash Sahadeo Coossa
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.